This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natera, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Susan J. Gross and Prenatal Aneuploidy Risk Assessment.
Introduction
Susan J. Gross is an inventor associated with Natera, Inc. Her work includes a patented approach for assessing aneuploidy risk using fetal DNA measurements in maternal blood or plasma samples.
Latest Patents
The patent listed for Susan J. Gross is “Systems and Methods for Determining Aneuploidy Risk Using Sample Fetal Fraction.” It describes systems, methods, and software that use genetic data from prenatal testing samples to estimate fetal fraction in a target sample. The model accounts for gestational age and maternal weight, then evaluates likelihoods across possible ploidy states. A Bayesian calculation combines those likelihoods with a previously determined risk score to produce an aneuploidy risk score. Gross is credited with 1 patent in the information provided.
Career Highlights
Gross’s listed patent concerns prenatal genetic screening and the computational assessment of aneuploidy risk. The disclosed method uses fetal fraction data to support risk estimation from maternal blood or plasma.
Collaborations
Gross is associated with Natera, Inc. Her listed coworkers include Allison Ryan and Katie Kobara.
Conclusion
Susan J. Gross’s listed patent describes a data-driven method for estimating aneuploidy risk by combining fetal fraction analysis with Bayesian probability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile